Evaluation of safety and efficacy of two primaquine dosing regimens for the radical treatment of P. vivax malaria in Vanuatu and Solomon Islands

Evaluation of safety and efficacy of two primaquine dosing regimens for the radical treatment of P. vivax malaria in Vanuatu and Solomon Islands

Objectives

To compare the efficacy of standard (0.25mg/kg/day for 14 days) and high-dose (0.5mg/kg/day for 14 days) primaquine in preventing early relapses from P. vivax in Solomon Islands and Vanuatu.

PI Institution(s)

Principal Investigator (PI)

Funding source(s)

Partner(s)

Key facts

  • Dates
    Apr 2013 to May 2015
    Funding amount
    $104,090
    Country
    • Solomon Islands
    • Vanuatu

MESA tags

  • Methodology
    Operational research, Product development & clinical research
    Theme(s)
    Drug-based strategies, P. vivax